Clinical trial
The IDEA Study (Individualized Decisions for Endocrine Therapy Alone)
NCT02400190 is registered in ClinicalTrials.gov with University of Michigan Rogel Cancer Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The IDEA Study (Individualized Decisions for Endocrine Therapy Alone)
- Lead sponsor
- University of Michigan Rogel Cancer Center
- Phase
- Not applicable
- Overall status
- Active, not recruiting
- Start date
- May 27, 2015
- Completion date
- May 31, 2028
- Enrollment
- 202 (actual)
- Sites
- 13
Conditions
As the registry lists them; a condition with its own page is linked.